Gregory J. Flesher - Net Worth and Insider Trading
Gregory J. Flesher Net Worth
The estimated net worth of Gregory J. Flesher is at least $35,661 dollars as of 2024-05-03. Gregory J. Flesher is the CEO of Eledon Pharmaceuticals Inc and owns about 8,718 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $21,621. Gregory J. Flesher is also the President and CEO of Reneo Pharmaceuticals Inc and owns about 8,000 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $14,040. Details can be seen in Gregory J. Flesher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory J. Flesher has not made any transactions after 2021-08-25 and currently still holds the listed stock(s).
Transaction Summary of Gregory J. Flesher
Gregory J. Flesher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory J. Flesher owns 3 companies in total, including Eledon Pharmaceuticals Inc (ELDN) , Adynxx Inc (ADYX) , and Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Gregory J. Flesher’s form 4 insider trades.
Insider Ownership Summary of Gregory J. Flesher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-21 | director & Chief Executive Officer |
| ADYX | Adynxx Inc | 2019-07-22 | director |
| RPHM | Reneo Pharmaceuticals Inc | 2021-08-25 | director & President and CEO |
Gregory J. Flesher Latest Holdings Summary
Gregory J. Flesher currently owns a total of 2 stocks. Among these stocks, Gregory J. Flesher owns 8,718 shares of Eledon Pharmaceuticals Inc (ELDN) as of May 21, 2019, with a value of $21,621 and a weighting of 60.63%. Gregory J. Flesher also owns 8,000 shares of Reneo Pharmaceuticals Inc (RPHM) as of August 25, 2021, with a value of $14,040 and a weighting of 39.37%.
Latest Holdings of Gregory J. Flesher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-21 | 8,718 | 2.48 | 21,621 |
| RPHM | Reneo Pharmaceuticals Inc | 2021-08-25 | 8,000 | 1.76 | 14,040 |
Holding Weightings of Gregory J. Flesher
Gregory J. Flesher Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory J. Flesher has made a total of 1 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the sale of 813 shares on May 21, 2019, which brought Gregory J. Flesher around $28,544.
According to the SEC Form 4 filings, Gregory J. Flesher has made a total of 1 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the acquisition of 8,000 shares on August 25, 2021, which cost Gregory J. Flesher around $64,000.
Insider Trading History of Gregory J. Flesher
- 1
Gregory J. Flesher Trading Performance
GuruFocus tracks the stock performance after each of Gregory J. Flesher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory J. Flesher is -10.08%. GuruFocus also compares Gregory J. Flesher's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory J. Flesher within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory J. Flesher's insider trading performs compared to the benchmark.
Performance of Gregory J. Flesher
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.04 | | | | | |
| Relative Return to S&P 500(%) | 9.82 | | | | | |
Gregory J. Flesher Ownership Network
Gregory J. Flesher Owned Company Details
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Gregory J. Flesher is the director & Chief Executive Officer of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
Over the past 18 months, Gregory J. Flesher made no insider transaction in Eledon Pharmaceuticals Inc (ELDN). Other recent insider transactions involving Eledon Pharmaceuticals Inc (ELDN) include a net purchase of 1,978,932 shares made by Biotechnology Value Fund L P , and a net purchase of 1,000 shares made by Steven Perrin .
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 1,979,932 shares were bought by its insiders, resulting in a net purchase of 1,979,932 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
Gregory J. Flesher Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory J. Flesher. You might contact Gregory J. Flesher via mailing address: 19900 Macarthur Blvd., Suite 550, Irvine Ca 92612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
